Ocular adverse events in PD-1 and PD-L1 inhibitors

BACKGROUND: Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye. METHODS: Two adverse event databases were retro...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Young, LeAnne, Finnigan, Shanda, Streicher, Howard, Chen, Helen X, Murray, James, Sen, H Nida, Sharon, Elad
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2021
Subjects:
Clinical/Translational Cancer Immunotherapy
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258670/
https://ncbi.nlm.nih.gov/pubmed/34226280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002119
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items